ezetimibe has been researched along with sodium ethylxanthate in 1 studies
Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (sodium ethylxanthate) | Trials (sodium ethylxanthate) | Recent Studies (post-2010) (sodium ethylxanthate) |
---|---|---|---|---|---|
2,484 | 563 | 1,465 | 7,743 | 58 | 361 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avorn, J; Brennan, TA; Carpenter, D; Choudhry, NK; Fischer, MA; Liberman, JN; Moffit, S; Myers, J; Shrank, WH; Slezak, J; Swanton, K; Tong, A | 1 |
1 other study(ies) available for ezetimibe and sodium ethylxanthate
Article | Year |
---|---|
Warnings without guidance: patient responses to an FDA warning about ezetimibe.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anticholesteremic Agents; Azetidines; Cohort Studies; Communication; Consumer Product Safety; Drug Utilization; Ezetimibe; Female; Guidelines as Topic; Humans; Insurance Claim Review; Male; Medication Adherence; Middle Aged; Sex; United States; United States Food and Drug Administration; Young Adult | 2012 |